Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

758 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Deep convolutional neural networks to predict cardiovascular risk from computed tomography.
Zeleznik R, Foldyna B, Eslami P, Weiss J, Alexander I, Taron J, Parmar C, Alvi RM, Banerji D, Uno M, Kikuchi Y, Karady J, Zhang L, Scholtz JE, Mayrhofer T, Lyass A, Mahoney TF, Massaro JM, Vasan RS, Douglas PS, Hoffmann U, Lu MT, Aerts HJWL. Zeleznik R, et al. Among authors: douglas ps. Nat Commun. 2021 Jan 29;12(1):715. doi: 10.1038/s41467-021-20966-2. Nat Commun. 2021. PMID: 33514711 Free PMC article.
Comparison of the use of hemodynamic support in patients ≥80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study).
Pershad A, Fraij G, Massaro JM, David SW, Kleiman NS, Denktas AE, Wilson BH, Dixon SR, Ohman EM, Douglas PS, Moses JW, O'Neill WW. Pershad A, et al. Among authors: douglas ps. Am J Cardiol. 2014 Sep 1;114(5):657-64. doi: 10.1016/j.amjcard.2014.05.055. Epub 2014 Jun 18. Am J Cardiol. 2014. PMID: 25037676 Clinical Trial.
2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with/without subclinical high-risk coronary plaque.
Zanni MV, Fitch KV, Feldpausch M, Han A, Lee H, Lu MT, Abbara S, Ribaudo H, Douglas PS, Hoffmann U, Lo J, Grinspoon SK. Zanni MV, et al. Among authors: douglas ps. AIDS. 2014 Sep 10;28(14):2061-70. doi: 10.1097/QAD.0000000000000360. AIDS. 2014. PMID: 25265074 Free PMC article.
Outcomes of anatomical versus functional testing for coronary artery disease.
Douglas PS, Hoffmann U, Patel MR, Mark DB, Al-Khalidi HR, Cavanaugh B, Cole J, Dolor RJ, Fordyce CB, Huang M, Khan MA, Kosinski AS, Krucoff MW, Malhotra V, Picard MH, Udelson JE, Velazquez EJ, Yow E, Cooper LS, Lee KL; PROMISE Investigators. Douglas PS, et al. N Engl J Med. 2015 Apr 2;372(14):1291-300. doi: 10.1056/NEJMoa1415516. Epub 2015 Mar 14. N Engl J Med. 2015. PMID: 25773919 Free PMC article. Clinical Trial.
The PROMISE trial: An inside perspective.
Hoffmann U, Douglas PS. Hoffmann U, et al. Among authors: douglas ps. J Cardiovasc Comput Tomogr. 2015 Jul-Aug;9(4):252-4. doi: 10.1016/j.jcct.2015.05.002. Epub 2015 May 8. J Cardiovasc Comput Tomogr. 2015. PMID: 26025047 No abstract available.
High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction.
Daubert MA, Massaro J, Liao L, Pershad A, Mulukutla S, Magnus Ohman E, Popma J, O'Neill WW, Douglas PS. Daubert MA, et al. Among authors: douglas ps. Am Heart J. 2015 Sep;170(3):550-8. doi: 10.1016/j.ahj.2015.06.013. Epub 2015 Jun 26. Am Heart J. 2015. PMID: 26385039 Clinical Trial.
758 results